Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07229534
PHASE4
Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes
Sponsor: Dong-A ST Co., Ltd.
View on ClinicalTrials.gov
Summary
This study is a multicenter, double-blind, active-controlled, randomized, parallel, phase IV clinical trial to evaluate the efficacy and safety of DA-5218 in patients with type 2 diabetes who have inadequate glycemic control with metformin
Official title: A Phase IV Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
238
Start Date
2025-11
Completion Date
2027-11
Last Updated
2025-11-17
Healthy Volunteers
No
Conditions
Interventions
DRUG
DA-5218
DA-5218 + DA-5218-C placebo
DRUG
DA-5218-C
DA-5218-C + DA-5218 placebo